Source: OKLAHOMA STATE UNIVERSITY submitted to
WHEAT GERM SUPPLEMENTATION WILL IMPROVE MARKERS OF GUT HEALTH, INFLAMMATION, AND INSULIN RESISTANCE IN OVERWEIGHT ADULTS
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
1018637
Grant No.
2019-67018-29260
Cumulative Award Amt.
$199,998.00
Proposal No.
2018-07994
Multistate No.
(N/A)
Project Start Date
Mar 1, 2019
Project End Date
Feb 28, 2022
Grant Year
2019
Program Code
[A1341]- Food Safety, Nutrition, and Health: Function and Efficacy of Nutrients
Project Director
Lucas, E.
Recipient Organization
OKLAHOMA STATE UNIVERSITY
(N/A)
STILLWATER,OK 74078
Performing Department
Nutritional Sciences
Non Technical Summary
The gut microbiota, epithelial cells and immune cells are vital in maintaining gut health and limiting gut permeability, thereby, preventing the onset of systemic inflammation, a factor linked to obesity and its co-morbidities. Products capable of preventing gut dysbiosis and promoting a healthy gut can have beneficial systemic outcomes and reduce the health burden of obesity. It is well established that fiber acts as a prebiotic and is important in maintaining gut health. However, studies examining whole foods with many other bioactive components as well as fiber are limited, especially in humans. One such product is wheat germ (WG), a by-product of wheat processing and an excellent source of omega-3 fatty acids, vitamin E, and fiber. A few studies have shown the health benefits of WG including gut modulatory potential, but the prebiotic functions of WG in humans remain in question and warrant further investigation.
Animal Health Component
(N/A)
Research Effort Categories
Basic
100%
Applied
(N/A)
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
7021549101020%
7014099104020%
7011549101060%
Goals / Objectives
The objective of this pilot study is to determine the effects of wheat germ supplementation on gut health and subsequent effects on markers of inflammation and insulin resistance in overweight individuals. Our overall hypothesis is that daily intake of WG, due to its fiber content and many other bioactive compounds will beneficially alter the gut microbiome and subsequently improve markers of inflammation and insulin resistance in overweight adults. We plan to test our hypothesis and accomplish the objective of this application by pursuing the following specific aims:Aim 1: To determine the effects of 4 weeks of WG supplementation on gut bacterial population and markers of gut health (i.e. fecal short chain fatty acids, immunoglobulin A and zonulin) in overweight adults.Working hypothesis: Due to the many bioactive compounds in wheat germ including its fiber content, wheat germ will selectively increase beneficial gut bacterial genera (e.g., Bifidobacteria, Akkermansia, Lactobacillus, Roseburia) and positively influence gut health of overweight adults.Aim 2: To correlate wheat germ-induced changes in the gut microbiome with markers of insulin resistance and inflammation in overweight adults.Working hypothesis: Wheat germ intake for 4 weeks will result in improved markers of insulin resistance and inflammation, correlating to improved gut health markers.Our primary outcome variables will be changes in fecal bacteria, immunoglobulin A, zonulin and short chain fatty acids while secondary outcome variables will be alterations in plasma markers of inflammation and insulin resistance. This study highlights the health benefits and economic value of this under-utilized by-product of wheat milling.
Project Methods
Approach. Upon Institutional Review Board approval, 40 healthy overweight adults (18-45 yrs old), regardless of gender will be recruited from Oklahoma State University and surrounding communities. The sample size (n=20/group) will have a power of 0.8859 for detecting a 1 standard deviation difference in the means of blood glucose between the two groups. Exclusion criteria will include: pre-existing chronic conditions such as diagnosed diabetes, heart disease, and cancer; tobacco and excessive alcohol use; taking mega-doses of antioxidant/vitamin supplements or medications that could interfere with study endpoints such as antibiotics, anti- inflammatory, and glucose-lowering medications; major surgery occurring within 6 months; pregnant or lactating; previous high intake of wheat germ or sensitivity to gluten and wheat products.After initial screening over the phone, potential subjects will be asked to come to the study site four times. At Visit 1, the study coordinator will a) provide a verbal and written explanation of the project, b) answer any questions regarding the study, c) get consent for participation, d) assess anthropometric parameters, health and medical history, and physical activity habits, and e) explain how to collect 3-day food records and fecal samples.The day after fecal sample collection (Visit 2), study participants will be asked to come to the study site fasting for 1) a baseline blood draw, 2) turn in baseline 3-day food records and fecal samples, 3) treatment assignment, 4) instructions to maintain their normal diet and physical activity levels throughout the study and how to store and consume the study supplements, and 5) provision of enough treatment regimen, calendar to record supplement intake, and log notebook to record any lifestyle changes.Treatment regimen will either be: a) wheat germ (40 g) given in the form of no-baked cookies (2 small cookies/day) containing ground wheat germ as the base flour (20 g wheat germ /cookie) or b) a fiber/calorie-matched control that is prepared similarly as the wheat germ cookie using corn flour instead of wheat germ. The treatment regimen will have the same number of calories. The wheat germ dose (40 g) is within the range of the dosage used in studies that reported beneficial effects of wheat germ. Shawnee Milling Co (Shawnee, OK), one of the leading independent mills in the US, will provide wheat germ and corn flour that will be used in the study. The study participants will be given bags containing the daily dose (2 cookies/ bag) of their treatment, asked to store the cookies in the refrigerator, and consume one bag of treatment regimen daily for 4 weeks.Participants will be asked to come again to the study site after 2 weeks (Visit 3) and at the end of 4-week supplementation (Visit 4). At Visit 3, participants will be asked to return calendars, used and unused supplement bags to monitor compliance, 3-day food records, and bring their log notebook to discuss any significant dietary and lifestyle changes as well as challenges associated with supplementation. All assessments and samples collected at baseline will be repeated in Visit 4. The 4-weeks study duration is adequate to see changes in bacterial population with dietary intervention. At Visits 1, 3 and 4, several questionnaires will be administered to inquire about health including recent use of medications, lifestyle, physical activity and dietary habits, as well as gut health including discomfort or symptoms and the character and the frequency of stools.At Visits 1, and 4, anthropometric parameters including body composition (Seca mBCA 514, Hamburg, Germany) will also be assessed using standard protocols. Fasting blood samples will also be collected during these visits. Blood samples will be centrifuged immediately to separate plasma and/or serum and stored at -70°C until analyses of markers of inflammation and IR. Our laboratory is experienced in assessing these markers.For fecal collection, study participants will be given a container to aseptically collect a fecal sample from their first bowel movement of the day. The participants will be asked to record the date and time of collection, store the sample in a provided cold storage, and bring to the study site the next day for Visit 2. If Visit 2 cannot be scheduled for the next day, study personnel will collect the fecal sample. This method of collection is as suitable as freezing of samples for preserving DNA fingerprints when immediate freezing is not possible. The fecal specimen will be homogenized manually using a spatula, aliquoted and stored at -70°C until use for analyses.Methods for Aim1: To determine the effects of 4 weeks of wheat germ supplementation on gut bacterial population and markers of gut health (i.e. fecal short chain fatty acids, immunoglobulin A and zonulin) in overweight adults.Analyses of gut bacterial population will be initiated after collection of all of the samples (pre- and post-supplementation) and performed in a random order. DNA will be extracted from frozen stool samples by the MoBio PowerSoil DNA Isolation Kit (MO BIO Laboratories, Inc.) following the manufacturer's protocol. Sequencing will be carried out on isolated fecal DNA and shipped on dry ice to Second Genome Inc. (San Francisco, CA). For markers of gut health, fecal homogenates will be prepared with appropriate buffers and supernatants will be collected. Intestinal permeability will be assessed by measuring the concentration of the intestinal tight junction protein zonulin in stool. Fecal concentrations of immunoglobulin A, the immunoglobulin abundant in mucosal areas that is important in promoting gut health by trapping dietary antigens and micro-organisms, downregulating the expression of pro-inflammatory molecules from commensal bacteria, and promoting the maintenance of beneficial bacteria, will also be assessed. Concentrations of zonulin and IgA will be analyzed in the supernatants in duplicates using commercially available kits from Immunodiagnostik AG (Germany) and Salimetrics LLC (Carlsbad, CA), respectively. Fecal short chain fatty acids will be determined via gas chromatography as we have previously described.Methods for Aim 2: To correlate wheat germ-induced changes in the gut microbiome with markers of insulin resistance and inflammation in overweight adults.Blood glucose and glycated hemoglobin will be determined using commercially available kits and analyzed by an automated clinical analyzer (Biolis, Brea, CA). Serum insulin and C- peptide will be analyzed using commercially available kits from Linco Research (St Charles, MO) and Diagnostic System Laboratories, Inc. (Webster, TX), respectively. Three markers of systemic inflammation, lipopolysaccharide binding protein (USCN Life Science and Technology, Houston, TX), high sensitivity C-reactive protein (Calbiotech, El Cajon, CA) and interleukin -6 (R&D Systems, Minneapolis, MN), will be assessed in the plasma using commercially available kits.

Progress 03/01/19 to 02/28/22

Outputs
Target Audience:This project is directed towards individuals who are at risk for metabolic diseases such as type 2 diabetes. This study found that wheat germ improved markers of glucose homeostasis in overweight adults. The findings of this study will provide a cost-effective supplementation option that could improve health of individuals that have problem with glucose control. Our results will apply to individuals of all racial and ethnic groups and levels of socioeconomic status that are at risk for developing type 2 diabetes. Changes/Problems:Our proposed treatment regimen is 40 g of wheat germ per day given in the form of no-baked cookies (2 small cookies/day) containing ground wheat germ as the base flour (20 g WG/cookie) or a fiber/calorie-matched control that is prepared similarly as the wheat germ cookie using corn flour instead of wheat germ. We searched for the best approach to deliver the wheat germ and opted to make our supplement in the form of two energy balls. During the preparation of the treatment regimen, we had to reduce the amount of wheat germ to 30 g. Our treatment regimen consisted of 30 g wheat germ or corn meal (control), 10 g peanut butter, 10 g honey, and 5 g powdered milk which provided approximately 227 calories for the two energy balls. One problem encountered in the study was the difficulty in the recruitment of the participants. Because of the study's stringent body mass index (BMI, between 25.0 - 30 kg/m2) requirements, many interested individuals were ineligible because many fell outside the overweight BMI range. We screened 130 individuals to obtain the necessary number of samples needed for the study. Additionally, the idea of collecting a fecal sample repulsed many individuals, as did blood collection. However, we were able to recruit enough people by the end of the year 2019. Another minor problem included the difficulty in drawing blood from certain participants. One subject in particular had small veins that a blood draw was impossible, so a drop of blood was obtained instead for lipid profile and HbA1c analysis. With help from other personnel trained on phlebotomy, we were able to draw blood from the other participants who had difficulty giving blood. As with everyone, the COVID-19 pandemic affected our operations. Because of it, we had to delay some laboratory analyses when the facility was shut down in April 2020. However, this time has allowed us to devote more time to other activities that can be done remotely, such as data entry, food intake and nutrient analysis, and statistical analyses. What opportunities for training and professional development has the project provided?Several graduate students learned many skills from conducting this study. They were trained on how to properly conduct a human study (interacting with study participants, confidentiality etc). Graduate students were also trained on the use of anthropometric and biochemical measurement tools for data collection. They were also shown how to prepare and store fecal and blood samples for laboratory analyses. The graduate students with the guidance of the Principal Investigator conducted all the laboratory procedures such as analysis of short-chain fatty acid, and inflammatory, gut health and metabolic markers. The graduate students were also involved with the statistical analyses, interpreting data, and writing the manuscript. An undergraduate student was overseen by the graduate students on the preparation of the treatment regimen, the use of ESHA Food Processor for diet analysis, how to properly conduct a clinical study, laboratory analyses, and data entry. The graduate student designated to be the study coordinator gained many skills and additional knowledge on the pathophysiology of chronic disease relevant to his career as a registered dietitian. How have the results been disseminated to communities of interest?We have presented the findings of this study at various professional meetings. 1. Dotimas L, Ojo B, Kaur A, Alake S, Dixon M, Davila El-Rassi G, Zhao J, Ice J, Emerson SR, Lucas EA. Wheat germ supplementation improves glucose homeostasis markers of overweight adults. ASN Nutrition meeting, June 2021, virtual. 2. Lucas EA. Wheat germ, gut health, and the prevention of obesity and insulin resistance. 2nd Helen Ocampo Memorial Lecture Series University of Santo Tomas, Manila, Philippines. June 2021, virtual 3. Lucas EA. Wheat germ supplementation will improve markers of gut health, inflammation, and insulin resistance in overweight adults. USDA Project Director's meeting, May 2021, virtual. 4. Lucas EA. Wheat germ, gut health, and the prevention of obesity and insulin resistance. Washington State University, December 2020, virtual. 5. Dotimas LG, Ojo B, Alake SE, Kaur A, Dixon MD, Emerson SR, Chowanadisai W, Smith BJ, Lucas EA. The effects of wheat germ supplementation on anthropometric, biochemical, and stool measures in overweight adults. ASN Nutrition meeting, June 2020, virtual. What do you plan to do during the next reporting period to accomplish the goals?We plan to submit the manuscript from the findings of this study to the American Journal of Clinical Nutrition.

Impacts
What was accomplished under these goals? Subject recruitment and supplementation, laboratory and statistical analyses, and the draft of the manuscript to publish the findings of the study has been written. We have also presented the findings of this study at various professional meetings. Our findings indicate that four weeks of wheat germ supplementation improved markers of glucose homeostasis and reduced the pro-inflammatory adipokine, resistin. However, these improvements are not due to changes in gut bacterial population.

Publications


    Progress 03/01/20 to 02/28/21

    Outputs
    Target Audience:This project is directed towards individuals who are at risk for metabolic diseases such as type 2 diabetes. This study found that wheat germ improved markers of glucose homeostasis in overweight adults. The findings of this study will provide a cost-effective supplementation option that could improve health of individuals that have problem with glucose control. Our results will apply to individuals of all racial and ethnic groups and levels of socioeconomic status that are at risk for developing type 2 diabetes. Changes/Problems:Our proposed treatment regimen is 40 g of wheat germ per day given in the form of no-baked cookies (2 small cookies/day) containing ground wheat germ as the base flour (20 g WG/cookie) or a fiber/calorie-matched control that is prepared similarly as the wheat germ cookie using corn flour instead of wheat germ. We searched for the best approach to deliver the wheat germ and opted to make our supplement in the form of two energy balls. During the preparation of the treatment regimen, we had to reduce the amount of wheat germ to 30 g. Our treatment regimen consisted of 30 g wheat germ or corn meal (control), 10 g peanut butter, 10 g honey, and 5 g powdered milk which provided approximately 227 calories for the two energy balls. One problem encountered in the study was the difficulty in the recruitment of the participants. Because of the study's stringent body mass index (BMI, between 25.0 - 30 kg/m2) requirements, many interested individuals were ineligible because many fell outside the overweight BMI range. We screened 130 individuals to obtain the necessary number of samples needed for the study. Additionally, the idea of collecting a fecal sample repulsed many individuals, as did blood collection. However, we were able to recruit enough people by the end of the year 2019. Another minor problem included the difficulty in drawing blood from certain participants. One subject in particular had small veins that a blood draw was impossible, so a drop of blood was obtained instead for lipid profile and HbA1c analysis. With help from other personnel trained on phlebotomy, we were able to draw blood from the other participants who had difficulty giving blood. As with everyone, the COVID-19 pandemic affected our operations. Because of it, we had to delay some laboratory analyses when the facility was shut down in April 2020. However, this time has allowed us to devote more time to other activities that can be done remotely, such as data entry, food intake and nutrient analysis, and statistical analyses. What opportunities for training and professional development has the project provided?Several graduate students learned many skills from conducting this study. They were trained on how to properly conduct a human study (interacting with study participants, confidentiality etc). Graduate students were also trained on the use of anthropometric and biochemical measurement tools for data collection. They were also shown how to prepare and store fecal and blood samples for laboratory analyses. The graduate students with the guidance of the Principal Investigator conducted all the laboratory procedures such as analysis of short-chain fatty acid, inflammatory, gut health and metabolic markers. The graduate students were also involved with the statistical analyses, interpreting data, and writing the manuscript. An undergraduate student was overseen by the graduate students on the preparation of experimental regimen, the use of ESHA Food Processor for nutrient analysis, how to properly conduct a clinical study, laboratory analyses, and data entry. The graduate student designated to be the study coordinator gained many skills and additional knowledge on the pathophysiology of chronic disease relevant to his career as a registered dietitian. How have the results been disseminated to communities of interest?We have presented the findings of this study at various professional meetings. Dotimas L, Ojo B, Kaur A, Alake S, Dixon M, Davila El-Rassi G, Zhao J, Ice J, Emerson SR, Lucas EA. Wheat germ supplementation improves glucose homeostasis markers of overweight adults. ASN Nutrition meeting, June 2021, virtual. Lucas EA. Wheat germ, gut health, and the prevention of obesity and insulin resistance. 2nd Helen Ocampo Memorial Lecture Series University of Santo Tomas, Manila, Philippines. June 2021, virtual Lucas EA. Wheat germ supplementation will improve markers of gut health, inflammation, and insulin resistance in overweight adults. USDA Project Director's meeting, May 2021, virtual. Lucas EA. Wheat germ, gut health, and the prevention of obesity and insulin resistance. Washington State University, December 2020, virtual. Dotimas LG, Ojo B, Alake SE, Kaur A, Dixon MD, Emerson SR, Chowanadisai W, Smith BJ, Lucas EA. The effects of wheat germ supplementation on anthropometric, biochemical, and stool measures in overweight adults. ASN Nutrition meeting, June 2020, virtual. What do you plan to do during the next reporting period to accomplish the goals?We plan to finalized the manuscript from the findings of this study to be submitted to the American Journal of Clinical Nutrition.

    Impacts
    What was accomplished under these goals? Subject recruitment and supplementation, laboratory and statistical analyses, and the draft of the manuscript to publish the findings of the study has been written. We have also presented the findings of this study at various professional meetings. Our findings indicate that four weeks of wheat germ supplementation improved markers of glucose homeostasis and reduced the pro-inflammatory adipokine, resisting. However, these improvements are not due to changes in gut bacterial population.

    Publications


      Progress 03/01/19 to 02/29/20

      Outputs
      Target Audience:This project is directed towards individuals who are at risk for metabolic diseases such as type 2 diabetes. If wheat germ is found to be beneficial for metabolic and gut health outcomes, the study will provide a cost-effective supplementation option that could improve health. The results will apply to individuals of all racial and ethnic groups and levels of socioeconomic status. Changes/Problems:One of the first problems encountered in the study was the difficulty in the recruitment of the participants. Because of the study's stringent body mass index (BMI, between 25.0 - 30 kg/m2) requirements, many interested individuals were ineligible because many fell outside the overweight BMI range. We screened 130 individuals to obtain the necessary number of samples needed for the study. Additionally, the idea of collecting a fecal sample repulsed many individuals, as did blood collection. However, we were able to recruit enough people by the end of the year 2019. Additional limitations included the difficulty in drawing blood from certain participants. One subject in particular had small veins that a blood draw was impossible, so a drop of blood was obtained instead for lipid profile and HbA1c analysis. With help from other personnel trained on phlebotomy, we were able to draw blood from the other participants who had difficulty giving blood. As with everyone, the COVID-19 pandemic affected our operations. Because of it, we had to postpone our laboratory activity in the meantime. However, this time has allowed us to devote more time to other activities that can be done remotely, such as data entry, food intake and nutrient analysis, and statistical analyses. What opportunities for training and professional development has the project provided?Several graduate students were trained on how to properly conduct a human study (interacting with study participants, confidentiality etc). Graduate students were also trained on the use of anthropometric and biochemical measurement tools for data collection. They were also shown how to prepare fecal samples for freeze drying and short-chain fatty acid analysis, how to properly conduct laboratory procedures such as ELISA. An undergraduate student was overseen by the graduate students on the preparation of experimental regimen, the use of ESHA Food Processor for nutrient analysis, and how to properly conduct a clinical study. The graduate student designated to be the study coordinator gained additional knowledge on the pathophysiology of chronic disease relevant to the student's future career as a registered dietitian. How have the results been disseminated to communities of interest?We have submitted and abstract to the annual meeting for the American Society of Nutrition (ASN 2020) but the meeting got cancelled due to COVID-19. We are still presenting some of our findings to the virtual meeting in June 2020. What do you plan to do during the next reporting period to accomplish the goals?During the next reporting period, we plan on finalizing the results of the gut microbiome analysis and short chain fatty acid analysis, as well as the other proposed assays. After which, statistical analyses will be conducted and the results will be presented as part of a graduate student thesis. The graduate student will have his thesis defense in Fall 2020 and the finding of this study will later be published in a peer-reviewed scientific journal.

      Impacts
      What was accomplished under these goals? Subject recruitment and supplementation have been completed. We are currently doing laboratory analysis. Analysis of fecal bacteria and short chain fatty acids are currently being finalized. Some markers of insulin resistance have been done and others will be analyzed as soon as possible

      Publications